| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.51 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.08 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |